1 West 1st Avenue
AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies and providers, we create unparalleled access, efficiency and reliability for human and animal health. Our 41,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #8 on the Fortune 500 with more than $200 billion in annual revenue. Learn more at amerisourcebergen.com.
Stock Symbol: ABC
We are united in our responsibility to create healthier futures.
As we pursue our purpose, we make a positive impact on the health of people and animals around the world.
357 articles with AmerisourceBergen
Learn how to unlock product potential in this step-by-step guide to making the most of your commercialization investments.
Total payment amounts are contingent on the number of governments that will agree to suspend their lawsuits as part of the deal.
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate virtually in the following upcoming investor conferences: Goldman Sachs 42nd Annual Global Healthcare Conference, to be held on June 8-11, 2021; and Baird Healthcare ESG Symposium, to be held on June 17, 2021.
AmerisourceBergen Corporation announced the completion of its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses for $6.275 billion in cash, subject to a customary working capital and net debt adjustment, and 2 million shares of AmerisourceBergen common stock.
Anivive Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Newest Lymphoma Treatment for Dogs
Strategic collaboration ensures veterinarians have rapid, easy access to LAVERDIA™-CA1 (verdinexor), the first oral tablet conditionally approved by the U.S. Food and Drug Administration (FDA) to treat lymphoma in dogs
Good Neighbor Pharmacy Surpasses 1 Million Doses of COVID-19 Vaccines Allocated through Federal Retail Pharmacy Program, Launches COVID-19 Vaccines Locator Tool
Good Neighbor Pharmacy, AmerisourceBergen’s network of independent community pharmacies, launched a COVID-19 Vaccines Pharmacy Locator Tool on MyGNP.com, a web-based platform designed to conveniently connect individuals with their local community pharmacy to receive COVID-19 vaccines.
AmerisourceBergen Corporation reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent year-over-year to $49.2 billion.
Theranos founder Elizabeth Holmes is back in the courtroom for the first time in 15 months for a three-day hearing ahead of her criminal fraud trial.
AmerisourceBergen Foundation Donates $700,000 to Boys & Girls Clubs of America to Roll Out COVID-19 Vaccine Education Programs Across the U.S.
The AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization focused on supporting health-related causes that enrich the global community, announced today a $700,000 donation to Boys & Girls Clubs of America to support COVID-19 vaccine education and awareness in an effort to remove barriers to vital healthcare access.
As the demand for biosimilar product information continues to grow among payers, Xcenda’s FormularyDecisions—a secure online platform that facilitates information exchange between manufacturers and healthcare decision-makers—announced the launch of a Biosimilars Hub.
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2021 on Wednesday, May 5, 2021, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 5, 2021.
AmerisourceBergen Closes $1,525,000,000 0.737% Senior Notes Due 2023 and $1,000,000,000 2.700% Senior Notes Due 2031
AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $1,525,000,000 aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the “2023 Notes”) and $1,000,000,000 aggregate principal amount of its 2.700% Senior Notes due March 15, 2031 (the “2031 Notes” and, together with the 2023 Notes, the “Notes”), in an underwritten registered public offering.
AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $1.525 billion aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the “2023 Notes”) and $1.0 billion aggregate principal amount of its 2.700% Senior Notes due March 15, 2031
Company received 100 percent on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ Workplace Equality
AUA Announces Collaboration Agreement with IntrinsiQ Specialty Solutions to Support Urologist Participation in the AUA Quality Registry
further advancing the science of urology, improving health care quality and ultimately improving the lives of the millions of people affected by prostate cancer, bladder cancer and other urologic disease.
AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent year-over-year to $52.5 billion.
AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors declared a quarterly dividend of $0.44 per common share, payable March 1, 2021, to stockholders of record at the close of business on February 12, 2021.
AmerisourceBergen Expands Commitment to Diversity and Inclusion as a Company Priority with Appointment of New SVP and Chief Diversity & Inclusion Officer, Dr. Lonie Haynes
As part of its commitment to fostering a diverse and inclusive culture, AmerisourceBergen, a global healthcare solutions leader, announced the appointment of Dr. Lonie Haynes as the company’s SVP and Chief Diversity & Inclusion Officer.
AmerisourceBergen Reaches Agreement with U. S. Centers for Disease Control and Prevention to Support Independent Retail Pharmacies’ Access to COVID-19 Vaccine
AmerisourceBergen Reaches Agreement with U. S. Centers for Disease Control and Prevention to Support Independent Retail Pharmacies’ Access to COVID-19 Vaccine VALLEY FORGE, Pa.--( BUSINESS WIRE )-- AmerisourceBergen has reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to include Good Neighbor Pharmacy and Elevate Provider Network members in the Federal Pharmacy Partnership Strategy for COVID-19 Vaccination. To suppo